T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.47B |
| 2 |
NXP Semiconductors
NXPI
|
+$1.73B |
| 3 |
Tesla
TSLA
|
+$1.7B |
| 4 |
Northrop Grumman
NOC
|
+$1.67B |
| 5 |
Dollar Tree
DLTR
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.29B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.85B |
| 3 |
Texas Instruments
TXN
|
+$1.82B |
| 4 |
Microsoft
MSFT
|
+$1.27B |
| 5 |
Booking.com
BKNG
|
+$1.18B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.1% |
| 2 | Technology | 17.78% |
| 3 | Consumer Discretionary | 15.32% |
| 4 | Financials | 14.61% |
| 5 | Industrials | 9.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
Alcoa
AA
$13.1B
| $3.37M | ﹤0.01% |
83,283
+5,571
| +7% | +$242K |
|
|
YELL
1502
DELISTED
Yellow Corporation Common Stock
YELL
| $3.35M | ﹤0.01% |
373,509
-1,000
| -0.3% | -$9.7K |
|
|
JHG
1503
DELISTED
Janus Henderson
JHG
| $3.35M | ﹤0.01% |
124,337
| – | – |
|
1504
Gentex
GNTX
$4.93B
| $3.34M | ﹤0.01% |
155,706
+390
| +0.3% | +$9.02K |
|
1505
Bloomin' Brands
BLMN
$924M
| $3.34M | ﹤0.01% |
168,735
-110
| -0.1% | -$2.15K |
|
1506
W.P. Carey
WPC
$16.1B
| $3.34M | ﹤0.01% |
53,012
-2,654
| -5% | -$171K |
|
1507
National Fuel Gas
NFG
$7.77B
| $3.33M | ﹤0.01% |
59,484
-1,549
| -3% | -$85.5K |
|
1508
Carlisle Companies
CSL
$15.2B
| $3.29M | ﹤0.01% |
26,978
-2,179
| -7% | -$266K |
|
1509
The Greenbrier Companies
GBX
$1.42B
| $3.28M | ﹤0.01% |
54,571
+192
| +0.4% | +$11.1K |
|
|
HIVE
1510
DELISTED
Aerohive Networks
HIVE
| $3.24M | ﹤0.01% |
787,004
+769,707
| +4,450% | +$3.2M |
|
1511
Oshkosh
OSK
$9.41B
| $3.22M | ﹤0.01% |
45,257
+642
| +1% | +$46.2K |
|
|
CTRL
1512
DELISTED
Control4 Corporation
CTRL
| $3.22M | ﹤0.01% |
93,704
-10,834
| -10% | -$334K |
|
|
SKX
1513
DELISTED
Skechers
SKX
| $3.21M | ﹤0.01% |
114,752
+20,049
| +21% | +$581K |
|
1514
Cabot Corp
CBT
$4.45B
| $3.2M | ﹤0.01% |
51,069
-2,832
| -5% | -$182K |
|
1515
HealthEquity
HQY
$8.83B
| $3.11M | ﹤0.01% |
32,897
+1,784
| +6% | +$154K |
|
1516
Enpro
NPO
$7.12B
| $3.09M | ﹤0.01% |
42,360
-73
| -0.2% | -$5.4K |
|
1517
The GEO Group
GEO
$4B
| $3.04M | ﹤0.01% |
121,038
+725
| +0.6% | +$18.5K |
|
1518
AC Immune
ACIU
$267M
| $3.04M | ﹤0.01% |
+379,400
| New | +$3.81M |
|
|
X
1519
DELISTED
US Steel
X
| $3.03M | ﹤0.01% |
99,317
+11,456
| +13% | +$370K |
|
1520
AGNC Investment
AGNC
$13B
| $3.02M | ﹤0.01% |
161,883
+3,176
| +2% | +$60.6K |
|
1521
NNN REIT
NNN
$8.79B
| $2.99M | ﹤0.01% |
66,619
+300
| +0.5% | +$13.5K |
|
1522
Alarm.com
ALRM
$2.74B
| $2.98M | ﹤0.01% |
51,914
-31,692
| -38% | -$1.59M |
|
1523
Lamb Weston
LW
$7.3B
| $2.97M | ﹤0.01% |
44,537
+323
| +0.7% | +$22.2K |
|
1524
Cedar Fair
FUN
$1.68B
| $2.96M | ﹤0.01% |
56,897
| – | – |
|
1525
Novartis
NVS
$288B
| $2.96M | ﹤0.01% |
38,376
-1,214
| -3% | -$89.7K |
|
Similar funds
T. Rowe Price Associates's Q3 2018 Portfolio in Review
As of Q3 2018, T. Rowe Price Associates held 2,658 positions worth $685B, up 4.7% from $654B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
T. Rowe Price Associates's Q3 2018 filing shows 77 new, 1,268 increased, 1,098 reduced and 77 closed positions. Its largest new stake was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 194,161 shares worth $208M. The largest sale was Broadcom, an estimated $3.29B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2018 buy was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 194,161 shares worth $208M.
- T. Rowe Price Associates added most to NVIDIA in Q3 2018, an estimated $2.47B increase.
- T. Rowe Price Associates's biggest Q3 2018 reduction was Broadcom, cutting an estimated $3.29B.
- T. Rowe Price Associates fully exited DCT Industrial Trust Inc. in Q3 2018, selling an estimated $345M.
- T. Rowe Price Associates's ten largest holdings make up 20% of its $685B portfolio in Q3 2018.
- T. Rowe Price Associates opened 77 new positions and closed 77 in Q3 2018.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $685B.
Based on T. Rowe Price Associates's 13F filing for Q3 2018, filed 14 Nov 2018.